Global Markets
S&P 500 — US Large Cap Index
NASDAQ 100 — Tech Growth Index
Dow Jones — Industrial Average
FTSE 100 — UK Blue Chips
Euro Stoxx 50 — Eurozone Leaders
DAX 40 — German Equities
CAC 40 — French Market Index
Nikkei 225 — Japan Benchmark
Hang Seng — Hong Kong Index
Shanghai Composite — China Mainland
ASX 200 — Australian Market
TSX Composite — Canada Index
Nifty 50 — India Large Cap
STI Index — Singapore Market
KOSPI — South Korea Index
Bovespa — Brazil Equities
JSE Top 40 — South Africa Index
IPC Index — Mexico Market
S&P 500 — US Large Cap Index
NASDAQ 100 — Tech Growth Index
Dow Jones — Industrial Average
FTSE 100 — UK Blue Chips
Euro Stoxx 50 — Eurozone Leaders
DAX 40 — German Equities
CAC 40 — French Market Index
Nikkei 225 — Japan Benchmark
Hang Seng — Hong Kong Index
Shanghai Composite — China Mainland
ASX 200 — Australian Market
TSX Composite — Canada Index
Nifty 50 — India Large Cap
STI Index — Singapore Market
KOSPI — South Korea Index
Bovespa — Brazil Equities
JSE Top 40 — South Africa Index
IPC Index — Mexico Market
AED • EUR • GBP • USD IBANs   |   CROSS BORDER FX   |   LOCAL CURRENCIES   |   GLOBAL COVERAGE
StocksTechnical AnalysisWall Street

Nasdaq Doww 1.1% While Nvidia 4% Selloff Pressures Semiconductors

Overall market sentiment on Wall Street remains fragile, dragged down by losses in large-cap tech, with Nvidia, Tesla, and Taiwan Semiconductor leading the declines. Big Tech as a whole is under pressure. However, other sectors in the S&P 500 are providing some cushion. The solid economic data also dampens hopes of aggressive Fed rate cuts, suggesting they may be smaller or delayed.

  • U.S. stock indexes opened lower on Wednesday. The US100 (Nasdaq) pulled back by nearly 1%, while the VIX rose by 2.5% as volatility crept higher.
  • A sharp selloff hit the semiconductor and tech sectors, with Nvidia (NVDA.US) falling almost 4% due to Chinese chips energy regulations.
  • Meanwhile, the oil & gas sector gained on rising crude oil prices. Cintas (CNTS.US) surged after the service company raised its full-year earnings and revenue guidance.
  • Durable goods orders in the U.S. came in stronger than expected, giving the U.S. dollar a slight lift.
  • GameStop (GME.US) saw renewed enthusiasm as the company received the green light to accumulate Bitcoin as a treasury asset.

U.S. Durable Goods Orders – February 2025:

  • Durable Goods Orders: +0.7% m/m (Forecast: +0.2%, Previous: 0.0%)
  • Core Durable Goods Orders (ex-transportation): +0.9% m/m (Forecast: -1.1%, Previous: +3.1%)

Source: xStation5

US100 Breaks Above EMA200, Then Pulls Back

The US100 briefly moved above the 200-day EMA (red line) before reversing lower. Despite days of higher buying volume, the index returned to a downward trend.

Source: xStation5

Company News

  • Chewy (CHWY.US) rose 4% after the online pet product retailer posted fourth-quarter net sales that exceeded expectations.
  • Dollar Tree (DLTR.US) gained 5% as the company announced the sale of its Family Dollar chain for approximately $1 billion to Brigade Capital Management and Macellum Capital Management—a decade after acquiring it.
  • Freeport-McMoRan (FCX.US) fell more than 3%, unable to hold earlier gains, despite the Trump administration signaling that industrial metal tariffs could be introduced in weeks rather than months.
  • GameStop (GME.US) surged over 10% after the struggling video game retailer, once a meme stock favorite, said its board had approved a plan to add Bitcoin to its treasury reserves.
  • Global-e Online (GLBE.US) rose 3% after Morgan Stanley upgraded the software firm to “overweight,” citing achievable growth targets.
  • Humacyte (HUMA.US) dropped nearly 30% after the biotech firm offered 25 million shares at $2 each — roughly a 30% discount to its previous closing price.
  • Playtika (PLTK.US) climbed 11% following a double upgrade from Bank of America, removing the last bearish analyst rating on the stock.
  • Summit Therapeutics (SMMT.US) rose 5% after Citi upgraded the biotech firm to “buy,” expressing stronger conviction in the company’s HARMONI-2 clinical trial.

Cintas Rides the Wave

Cintas Corporation shares gained around 4% on Wednesday after the company reported fiscal third-quarter results ahead of analyst expectations and raised its full-year outlook. Wall Street appreciates, that professional cleaning services company lifts expectations despite unfavorable macro data from the US.

  • Earnings per share (EPS) came in at $1.13, surpassing the $1.05 estimate. Revenue rose to $2.61 billion, just above the $2.6 billion consensus.
  • The company’s gross margin improved to 50.6% from 49.4% a year earlier, exceeding the projected 50%. This reflects efficient cost control and robust operational execution — a notable achievement in the services sector.
  • For fiscal year 2025, Cintas raised its EPS guidance to $4.36–$4.40, from the prior $4.28–$4.34 range. Analysts had expected $4.33. Revenue guidance was also lifted slightly to $10.28–$10.31 billion.
  • Management noted a $15 million cut at the top end of the revenue range due to unfavorable foreign exchange movements seen in Q3, with a similar impact expected in Q4.

Net interest expense for the year is projected at approximately $100 million, up from $95 million in FY 2024, due to higher variable-rate debt. The effective tax rate is forecast at 20.2%.

Cintas Corp (CNTS.US, D1 Interval) Cintas shares are trading above the 200-day exponential moving average (EMA200), signaling a potential return to the uptrend.

Source: xStation5

The material on this page does not constitute financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other specific needs. All information provided, including opinions, market research, mathematical results and technical analyzes published on the Website or transmitted To you by other means, it is provided for information purposes only and should in no way be construed as an offer or solicitation for a transaction in any financial instrument, nor should the information provided be construed as advice of a legal or financial nature on which any investment decisions you make should be based exclusively To your level of understanding, investment objectives, financial situation, or other specific needs, any decision to act on the information published on the Website or sent to you by other means is entirely at your own risk if you In doubt or unsure about your understanding of a particular product, instrument, service or transaction, you should seek professional or legal advice before trading. Investing in CFDs carries a high level of risk, as they are leveraged products and have small movements Often the market can result in much larger movements in the value of your investment, and this can work against you or in your favor. Please ensure you fully understand the risks involved, taking into account investments objectives and level of experience, before trading and, if necessary, seek independent advice.

Register a Revolut Business Account
```

Market Analysis & Disclaimer

The market information, analysis, commentary, forecasts and opinions contained in this publication are provided by Octalas Group Ltd on behalf of Today Markets and Currency Hedger using information and data obtained from sources believed to be reliable. However, Octalas Group Ltd, Today Markets and Currency Hedger do not warrant or guarantee the accuracy, completeness or timeliness of the information presented and accept no responsibility for any loss or damage arising from reliance upon information contained herein, to the extent permitted by applicable law.

Market forecasts, expectations and opinions are based on analysis of available information and a number of assumptions regarding economic, financial, political and market conditions. Such assumptions may prove to be incorrect, and actual market developments may differ materially from those described or anticipated.

Nothing contained in this publication constitutes investment advice, financial advice, a personal recommendation, an offer, solicitation or invitation to buy, sell or otherwise transact in any financial instrument or investment product. The information is provided for general informational and educational purposes only and does not take into account the investment objectives, financial situation, experience or particular circumstances of any individual reader.

Past performance is not indicative of future results. Financial markets, including foreign exchange, commodities, equities, derivatives and other financial instruments, involve risk and prices can move rapidly. Readers should conduct their own independent research and, where appropriate, obtain advice from an appropriately authorised financial professional before making any investment or trading decision.

Where this publication refers to Today Markets, it represents market news, research, analysis and commentary published for informational purposes. Where Currency Hedger is referenced, it represents commentary concerning foreign exchange, currency exposure, international payments and hedging-related topics. References to particular financial instruments, markets, companies, currencies or commodities should not be interpreted as a recommendation to transact in them.

Octalas Group Ltd, Today Markets and Currency Hedger may have commercial interests or relationships with businesses, financial-service providers, technology providers or other market participants mentioned in their publications. Where relevant, such relationships or interests may create potential conflicts of interest. Appropriate measures are intended to be taken to ensure that published analysis and commentary are presented objectively and that commercial considerations do not determine the substance of market analysis.

The views expressed in this publication are those of the author or contributors at the time of publication and may change without notice as market conditions develop. Readers should not assume that any information contained herein has been updated following publication.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Check Also
Close
Back to top button